Antenatal Influenza Associated With Late Pregnancy Loss and Low Birthweight
Investigators quantified the risk of antenatal influenza and examined its association with perinatal outcomes.
All articles by Sweta Gupta
Age-Related Priming Determined Breadth of Influenza A(H3N2) Antibody Landscape in Children
Researchers assessed whether pre-existing antibodies to influenza, which are shaped by early infection and subsequent exposures, impact children’s responses to influenza vaccination.
Determining the Optimal Level of Neutralizing Antibodies Key for COVID-19 Plasma Therapy
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
Challenges in Assessing the Efficacy of COVID-19 Vaccines
Study authors explored the challenges in assessing the efficacy of COVID-19 vaccines and discussed the caveats needed to interpret efficacy endpoints.
Remdesivir Superior to Placebo in Hospitalized Patients With COVID-19
Researchers assessed if use of intravenous remdesivir in hospitalized patients with coronavirus disease 2019 infection affected time to recovery and clinical status on days 15 and 29.
People With HIV May Have a Higher Susceptibility to COVID-19
Investigators compared the prevalence of HIV among patients hospitalized with COVID-19 compared to the general population and sought to determine whether patients with HIV had higher susceptibility to COVID-19.
Rising Trend of Obstructive Sleep Apnea in the Aging HIV Population
Investigators assessed the incidence of obstructive sleep apnea in patients with HIV and the comorbidities associated with increased incidence.
Azithromycin Added to Standard of Care in Severe COVID-19 Does Not Improve Outcomes
Study authors assessed whether azithromycin in addition to a hydroxychloroquine regimen shows positive results in clinical improvement or mortality reduction in patients hospitalized with severe COVID-19.
Performance of 5 Immunoassays for SARS-CoV-2 Compared
A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.
Decrease in Antibodies to SARS-CoV-2 Seen Over 60 Days Among Health Care Personnel
Investigators conducted a single-center study to evaluate the anti-SARS-CoV-2 antibodies at baseline and 60 days in health care personnel, who are at particular risk if antibodies level decline.
-
Loading...
-
Loading...
Next post in Lung Infection
